On September 5, Brazil’s National Health Surveillance Agency (ANVISA) published amendments for pyrimethanil, mancozeb, amicarbazone, diquat, spiromesifen, chlorothalonil, benzyladenine, chlorantraniliprole, imazamox, and ethiprole.
MRL changes from these amendments will display in the Global MRL Database on September 7, 2016.
On July 28, Brazil's National Health Surveillance Agency (ANVISA) published draft amendments proposing changes for the following active ingredients (in Portuguese): amicarbazone, chlorantraniliprole, mancozeb, pyrimethanil, imazamox, spiromesifen, chlorothalonil, and benzyladenine.
Comments on these proposals must be submitted by August 26, 2016. Relevant proposed MRLs will show in the Global MRL Database on July 29.
On May 19, Japan's Ministry of Health, Labour and Welfare (MHLW) notified the WTO of proposed MRL changes for the following active ingredients:
Comments on updated MRLs are due by July 18, 2015, and relevant proposed changes will be added to Global MRL Database.
Brazil's National Health Surveillance Agency (ANVISA) recently published draft amendments proposing MRLs for the following active ingredients (links in Portuguese): glufosinate, kresoxim-methyl, chlorantraniliprole, fluazifop-P, flutriafol, metalaxyl-M, acibenzolar-S-methyl, benzyladenine, lambda-cyhalothrin, imazapyr and imazapic.
Comments on these proposals must be submitted by October 31, 2014. Relevant changes will not appear in MRL Database unless they are officially adopted by ANVISA.